Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could seeing your own health data improve cancer care?

NCT ID NCT03995082

Knowledge-focused Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study looks at whether giving breast cancer patients a graph of their own survey results—called Patient Reported Outcome Measures—helps them engage more with their care. About 925 women with a new breast cancer diagnosis will be randomly assigned to either receive their survey results or not. Researchers will then compare patient satisfaction, use of support services, and communication with doctors between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient Reported Outcome Measure (PROM) survey result feedback
What this could lead to
If sharing survey results improves patient engagement, it could lead to better communication and more personalized care for breast cancer patients.
What could go wrong
This is an early-stage study focused on measuring engagement, not a treatment. Results may not change outcomes, and the benefit could vary widely among patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 925 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2019

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

We will target all patients with a new diagnosis of breast cancer who present to the breast multi-disciplinary clinic. Inclusion: * Adult (18 years of age or more) * Female * Patients with breast cancer * Patients who can independently complete surveys Exclusion * Age \<18 years * Male * Patients who cannot independently complete surveys

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Patient reported outcomes

Contacts and locations

Locations

  • Cherry Creek Medical Center

    Denver, Colorado, 80206, United States

  • Highlands Ranch Hospital

    Highlands Ranch, Colorado, 80129, United States

  • University of Colorado Hospital

    Denver, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.